Incidence and Predictors of Contrast Induced Nephropathy after Coronary Intervention at College of Medical Sciences
Teaching Hospital, Bharatpur. In Nepal, prevalence of cardiovascular disease and its risk factors are high. 7 It is expected that the increasing disease burden will lead to increasing diagnostic and therapeutic cardiac interventions exposing patients to contrast media.
Recognizing which of our patients are at high risk and have the potential for contrast-induced acute kidney injury is the key to improve outcomes of these patients. In this regards identification of risk factors for CIN in Nepalese population undergoing coronary angiogram/PCI will help risk stratification and help undertake preventive measures for CIN. In this background this cross sectional observational hospital based descriptive study was undertaken to study the incidence of CIN and to identify risk factors (predictors) for the development of CIN in patients undergoing catheterization in CMS-TH, Bharatpur, Nepal.
MethOdS

Study Population
A total of 540 patients undergoing coronary angiogram/PCI from 2011 to 2013 were enrolled in the study by convenient sampling technique. Two hundred ten patients were excluded from the study due either due to non-availability of follow up data of serum creatinine, lost to follow up or death of the patients before completion of the study period.
Therefore, a total of 330 patients who underwent elective or emergency coronary interventional procedure were enrolled. All patients received evidence based standard pre and post procedural care as per Guideline directed medical management. All patients provided written informed consent for cardiac catheterization and PCI and for the data collection related to CIN for the study. Patients were excluded from the study if they did not provide the consent.
Institutional ethical review committee approved the study. 
Study Protocol
Clinical Definitions
Contrast-induced nephropathy was defined as an increase of >25% or >0.5 mg/dl in pre-PCI serum creatinine at or after 48 h after PCI. 8, 9 Chronic kidney disease, 9 
StatiStical analYSiS
Data were entered on MS XP sheet and then was converted The variables chosen by the model included all the potential confounding variables. All hypothesis testing was two tailed.
A p value < 0.05 was considered as statistically significant.
reSultS
The baseline clinical characteristics of study population are given in Table 1 . 138.20±91.34 ml; p = 0.254). There was also no significant difference of proportion in diagnostic procedure, PCI and emergency cases for the CIN group and the non-CIN group.
Subgroup Analysis Elderly Patients (≥ 70 years):
A total of 72 patients were aged 70 years and above. The incident of CIN in elderly was 12.5% and that of age below 70 years was 6.97%. The difference was statistically significant (p=0.01).
Diabetes mellitus
The incidence of CIN in diabetic patients was higher than non-diabetic population and it was statistically significant (12.5% in diabetes Vs. 6.97% in no-diabetic patients, p=0.01).
Due to relatively small number of patients in diabetes with pre-existing renal impairment size it was not possible to stratify the incidence of CIN in patients with preexisting renal dysfunction in diabetics to that diabetes without preexisting renal dysfunction.
Preexisting impairment of renal function
The incidence of CIN in patients with preexisting impairment of renal function (baseline creatinine clearance < 60 ml/min) was 45.45% vs. 4.04% in patients with baseline creatinine clearance ≥ 60 ml/min (p < 0.001).
There was no difference regarding the amount of contrast agent administered between patients with different baseline creatinine clearance.
PCI group
The incidence of CIN was similar for the PCI and non-PCI subgroup (2.7% vs. 3.0%; p = 0.65). In addition, the incidence of CIN in elective cases and in emergency cases also showed no significant difference (2.9 % vs. 2.6 %; p = 0.69).
Anemia group
Out of 120 anemic patients, 12 (10%) patients developed CIN. The incidence of CIN in anemic patients was significantly higher than in non-anemic patients (10% vs.
7.14%; p < 0.001).
Multivariate Logistic Regression Analysis
Variables included in the first step of the multivariate analysis with other large studies is given in Table 2 .
The incidence of CIN in patients undergoing PCI in our study was 8.18% which was much higher than the results of Rihalet al. 18 .
The incidence of CIN in patients with impaired renal function (e-GFR <60ml/min) was higher than those with preserved renal function (45.45 % vs. 4.04%). This was consistent with previous studies, which suggested a higher incidence of CIN in patients with greater reduction in renal function.
18, 21,22
In a series of 7,586 patients undergoing cardiac catheterization, Rihal et al. The in-hospital mortality rate in patients developing renal insufficiency is directly related to the magnitude of the increase in the serum creatinine concentration.
5,24
A study by Marenzi et al demonstrates that CIN is a frequent complication after PCI in AMI even in patients with normal baseline renal function, and is associated with increased in-hospital morbidity, mortality and prolonged hospitalization. procedures and found that the mortality rate in patents without renal failure was 7%, compared with 34% in those with renal failure. These data suggest that the development of CIN is highly correlated with death during the index hospitalization as well as during long-term follow-up.
CIN in elderly (>70 years) Patients
In this study, the incidence of CIN in patient's ≥ 70 years was 12.5%. The result was consistent with the finding of McCullough et al. 5 Study by Marenzi et al. and Cigarroa et al. 25, 26 reported ≥ 70 years of age appeared to be an independent predictor of CIN. Rich and Crecelius 27 reported an incidence of CIN in patients of the same age group to be 11%. The reasons for this higher risk of CIN have not been studied but are probably multifactorial, including age-related changes in renal function, the presence of multivessel disease, and more difficult vascular access due to tortuosity and calcification of the vessels requiring relatively large amounts of contrast.
CIN in Diabetes Mellitus
Besides preexisting impairment of renal function, diabetes mellitus is another well-recognized risk factor for CIN. 
Clinically important CIN usually occurs in subset of
10, 18
In the present study, the diabetes alone was an independent risk factor for the development of CIN. The incidence of CIN in patients with preexisting renal dysfunction was very high in both diabetic and non diabetic. As the numbers of patients were small (9 in diabetics and 20 in nodiabetic with e-GFR <60ml/min), the inference may not be valid and it is advisable to conduct a study with appropriate sample size for definite conclusion to make. Mehran et al. 10 showed that in diabetics with preserved renal function and absence of other risk factors, the rate of CIN was comparable to that in a healthy population. Lautin et al. 28 reported that the incidence of CIN was rather low (2%) in patients with neither diabetes nor azotemia, but significantly higher (16%) in individual patients with diabetes but preserved renal function, and much higher (38%) in patients who had both diabetes and azotemia. In a large study of 1,196 patients, 
CIN in Preexisting Impairment of Renal Function
Multivariate logistic regression analysis confirmed that baseline creatinine clearance was an independent risk factor for CIN in the study population. This result was consistent with other studies. 19, 30 Rihal et al. 18 used multivariate analysis;
baseline serum creatinine was identified as an independent predictor of CIN. In multivariate analysis by McCullough et al. 30 creatinine clearance is an independent predictor of CIN requiring dialysis after coronary intervention. Renal function deterioration after exposure to contrast medium is common in patients with impaired renal function. 27 McCullough et al. 30 found that creatinine clearance of 30ml/ min or less markedly increased the incidence and severity of CIN. The renal function deterioration is an important predictor of in-hospital mortality. Dangaset al. 19 found CIN was one of the most powerful predictors of 1-year mortality in patients with preexisting chronic kidney disease or preserved eGFR.
CIN in Patients with Anemia
Anemia has been incorporated as risk factor for development of CIN. Our study demonstrated that presence of anemia was an independent risk factor for contrast-induced nephropathy.
When anemia was introduced into the multivariate model it In the present study, the incidence of CIN in patients with anemia was 10% and without anemia was 7.14%. In this patients with anemia were older than non-anemic group.
This was possibly the mechanism to explain an association between anemia and higher incidence of CIN. Kim et al. 32 reported that contrast media could increase oxygen affinity of hemoglobin, so oxygen delivery to the peripheral tissues might be impaired. Local renal hypoxia can be more aggravated in patients with low hemoglobin after exposure to contrast media, hence the combination of contrast-induced vasoconstriction and anemia may decrease oxygen delivery sufficiently to cause renal medullary hypoxia. Thus, it is intuitive that anemia may play a role in CIN risk. Nikolsky and colleagues 20 demonstrated that patients with the lowest eGFR and hematocrit had the highest rates of CIN. The threshold hematocrit at which the risk of CIN increased was < 41.2% in men and < 34.4% in women. Anemia-induced deterioration of renal ischemia and hypoxia may be one reason for the higher incidence of CIN in anemic patients.
Role of Contrast Media
There is a debate whether the quantity of contrast agent predicts the degree of renal dysfunction. Some studies McCullough et al. 34 found that 100 ml contrast medium was the cutoff dose below which there was no CIN requiring dialysis undergoing coronary angiography. Brigurociet al. 35 identified a volume of 140 ml as the best cutoff value for predicting the occurrence of CIN. These data emphasize the necessity for limiting the amount of contrast dye administered when dealing with patients with impaired renal function.
This study has certain limitations. The sample size in the study is relatively small. However, certain risk factors could still be identified in this study. The significant loss to follow up might also have lead to sample selection bias leading inappropriate incidence of CIN.
Because the follow-up assessment time of renal function in our study was at pre-specified, therefore, we might have missed a later (after 48 hours) increase in serum creatinine.
This might have resulted in a slight underestimation of CIN.
We 
